Danazol

CHEMBL1479 Phase 4 Disetujui Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
337.5 g/mol
LogP
3.8
Phase
4

A synthetic androgen derived from ethisterone that suppresses pituitary gonadotropins, used to treat endometriosis, fibrocystic breast disease, and hereditary angioedema. Its androgenic side effects including acne, voice changes, and liver toxicity have limited its use.

Berat Molekul

337,5000 g/mol

LogP

3,80

TPSA

46,30 Ų

Lipinski RO5

Lulus

Area Terapeutik

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Struktur 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C

InChI

InChI=1S/C22H27NO2/c1-4-22(24)10-8-18-16-6-5-15-11-19-14(13-23-25-19)12-20(15,2)17(16)7-9-21(18,22)3/h1,11,13,16-18,24H,5-10,12H2,2-3H3/t16-,17+,18+,20+,21+,22+/m1/s1

Molecular Formula

C22H27NO2

HBD / HBA

1 / 3

Ikatan yang Dapat Dirotasi

1

Atom Berat

25

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

A synthetic androgen derived from ethisterone that suppresses pituitary gonadotropins, used to treat endometriosis, fibrocystic breast disease, and hereditary angioedema. Its androgenic side effects including acne, voice changes, and liver toxicity have limited its use.

Yes, Danazol is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1479. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 28417. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.